ATE263833T1 - Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen - Google Patents

Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen

Info

Publication number
ATE263833T1
ATE263833T1 AT99961649T AT99961649T ATE263833T1 AT E263833 T1 ATE263833 T1 AT E263833T1 AT 99961649 T AT99961649 T AT 99961649T AT 99961649 T AT99961649 T AT 99961649T AT E263833 T1 ATE263833 T1 AT E263833T1
Authority
AT
Austria
Prior art keywords
cells
hematopoietic system
recipient
depletated
compositions
Prior art date
Application number
AT99961649T
Other languages
English (en)
Inventor
Edmund K Waller
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Application granted granted Critical
Publication of ATE263833T1 publication Critical patent/ATE263833T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT99961649T 1998-11-11 1999-11-10 Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen ATE263833T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18957798A 1998-11-11 1998-11-11
PCT/US1999/026773 WO2000027998A2 (en) 1998-11-11 1999-11-10 Method and compositions for improving allogeneic hematopoietic cell transplantation

Publications (1)

Publication Number Publication Date
ATE263833T1 true ATE263833T1 (de) 2004-04-15

Family

ID=22697926

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99961649T ATE263833T1 (de) 1998-11-11 1999-11-10 Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen

Country Status (9)

Country Link
EP (1) EP1123384B1 (de)
JP (1) JP2002529476A (de)
KR (1) KR20010090008A (de)
CN (1) CN1213143C (de)
AT (1) ATE263833T1 (de)
AU (1) AU779039B2 (de)
CA (1) CA2351194A1 (de)
DE (1) DE69916302T2 (de)
WO (1) WO2000027998A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3078738B1 (de) 2007-08-31 2020-05-20 Whitehead Institute for Biomedical Research Wnt-weg-stimulierung bei der umprogrammierung somatischer zellen
CA2823782C (en) * 2011-01-10 2019-05-07 Samuel Strober Enhancement of allogeneic hematopoietic stem cell transplantation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409813A (en) * 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations

Also Published As

Publication number Publication date
CA2351194A1 (en) 2000-05-18
CN1213143C (zh) 2005-08-03
AU779039B2 (en) 2005-01-06
EP1123384B1 (de) 2004-04-07
DE69916302D1 (de) 2004-05-13
WO2000027998A3 (en) 2000-07-27
CN1333688A (zh) 2002-01-30
WO2000027998A2 (en) 2000-05-18
KR20010090008A (ko) 2001-10-17
JP2002529476A (ja) 2002-09-10
EP1123384A2 (de) 2001-08-16
DE69916302T2 (de) 2005-05-04
AU1817800A (en) 2000-05-29

Similar Documents

Publication Publication Date Title
JP2002517227A5 (ja) 造血幹細胞を試験管内で維持する方法と組成物
Yañez et al. Adipose tissue‐derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft‐versus‐host disease
Garcia‐Castro et al. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool
EP2048228B8 (de) Humane Lebervorläufer
WO2003012060A3 (en) Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
WO2005097979A3 (en) Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof
SG147305A1 (en) Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
CA2387542A1 (en) Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation
WO2008036374A3 (en) Allogeneic stem cell transplants in non-conditioned recipients
WO2006047743A3 (en) Swine multipotent adult progenitor cells
WO2001007568A3 (en) Muscle cells and their use in cardiac repair
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
EP1077599A4 (de) Brassica-transformation durch teilchenbeschuss
JP2009517078A5 (de)
DK0952772T3 (da) Fremgangsmåder til anvendelse af mononukleare phagocytter til at fremme axonal regeneration
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
GB9825096D0 (en) Cells,culture methods and their uses
WO2002017935A3 (en) A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
WO2003080798A3 (en) Muscle cells and their use in cardiac repair
WO2005017115A3 (en) Cord blood-derived hematopoietic progenitor cells
ATE263833T1 (de) Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen
DE69737455D1 (de) Definierte systeme zur kultivieurng epithelialer zellen und anwendung derselben
WO2003029432A3 (en) Human mesenchymal progenitor cell
GB2379446A (en) Cells,culture methods and their uses
DK1140149T3 (da) Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation......

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties